BARCLAYS PLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$3,810,000
+155.9%
202,032
+59.7%
0.00%
+100.0%
Q2 2019$1,489,000
+558.8%
126,526
+663.8%
0.00%
Q1 2019$226,000
-74.8%
16,565
-81.1%
0.00%
-100.0%
Q4 2018$896,000
-26.5%
87,479
+19.5%
0.00%0.0%
Q3 2018$1,219,000
+124.1%
73,228
+112.4%
0.00%
Q2 2018$544,000
+19.0%
34,475
-4.1%
0.00%
Q1 2018$457,000
+196.8%
35,952
+168.2%
0.00%
Q4 2017$154,000
-91.5%
13,407
-91.0%
0.00%
-100.0%
Q3 2017$1,821,000
+1114.0%
148,656
+1029.1%
0.00%
Q2 2017$150,000
-63.3%
13,166
-33.0%
0.00%
Q1 2017$409,000
-65.9%
19,643
-65.9%
0.00%
-100.0%
Q4 2016$1,198,000
+1202.2%
57,557
+1954.1%
0.00%
Q3 2016$92,000
+360.0%
2,802
+245.9%
0.00%
Q2 2016$20,000
-99.7%
810
-99.7%
0.00%
-100.0%
Q1 2016$6,336,000
+112.3%
263,991
+191.8%
0.01%
+150.0%
Q4 2015$2,985,000
+687.6%
90,472
+665.0%
0.00%
Q3 2015$379,000
+1622.7%
11,827
+2791.7%
0.00%
Q2 2015$22,000
-15.4%
409
-56.9%
0.00%
Q1 2015$26,000
+36.8%
949
+46.0%
0.00%
Q4 2014$19,000
+5.6%
650
-58.1%
0.00%
Q3 2014$18,000
+350.0%
1,550
+780.7%
0.00%
Q2 2014$4,0001760.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Novo Holdings A/S 6,402,366$128,496,0006.43%
Cormorant Asset Management, LP 150,000$3,011,0000.80%
PFM Health Sciences, LP 738,027$14,812,0000.30%
Partner Investment Management, L.P. 27,893$560,0000.11%
Spark Investment Management LLC 32,100$642,0000.10%
PointState Capital LP 275,000$5,519,0000.07%
DRIEHAUS CAPITAL MANAGEMENT LLC 97,809$1,963,0000.06%
CADIAN CAPITAL MANAGEMENT, LP 100,000$2,007,0000.06%
Nicholas Investment Partners, LP 50,456$1,013,0000.06%
Baker Brothers Advisors 153,350$3,078,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders